News Alert: Pfizer, BioNTech ask FDA to allow children’s coronavirus vaccine, a key step toward immunizations for kids age 5 to 11

Vaccine maker Pfizer and its German partner BioNTech on Thursday submitted a request to the Food and Drug Administration, seeking emergency use authorization for its mRNA vaccine for children age 5 to 11. If authorized, this would be the first coronavirus vaccine available to U.S. children younger than 12. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

Sign up for alerts News Alert Oct. 7, 8:44 a.m. EDT Pfizer, BioNTech ask FDA to allow children's coronavirus vaccine, a key step toward immunizations for kids age 5 to 11 Vaccine maker Pfizer and its German partner BioNTech on Thursday submitted a request to the Food and Drug Administration, seeking emergency use authorization for its mRNA vaccine for children age 5 to 11. If authorized, this would be the first coronavirus vaccine available to U.S. children younger than 12. Read more   Advertisement

Manage my email newsletters and alerts | Unsubscribe | Privacy Policy | Help You received this email because you signed up for news alerts or because it is included in your subscription. ©2021 The Washington Post | 1301 K St NW, Washington DC 20071